Total endoscopic management (TEM approach) of children with non-compliant neuropathic bladder: a preliminary report.

[1]  Sherif M. Soliman,et al.  Botulinum-A toxin: solo treatment for neuropathic noncompliant bladder. , 2007, The Journal of urology.

[2]  S. Payabvash,et al.  Intravesical injection of botulinum toxin type A: management of neuropathic bladder and bowel dysfunction in children with myelomeningocele. , 2006, Urology.

[3]  A. Kirsch,et al.  The modified sting procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. , 2004, The Journal of urology.

[4]  S. Bauer,et al.  Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. , 2004, The Journal of urology.

[5]  A. Khoury,et al.  Long-term evaluation of metabolic profile and bone mineral density after ileocystoplasty in children. , 2003, The Journal of urology.

[6]  T. Michael,et al.  Efficacy of botulinum-a toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results. , 2002, Urology.

[7]  B. Schurch,et al.  Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. , 2000, The Journal of urology.

[8]  G. Mattioli,et al.  Treatment of vesico-ureteric reflux in children with neuropathic bladder: a comparison of surgical and endoscopic correction. , 1999, Journal of pediatric surgery.

[9]  E. Cheng,et al.  Surgical versus endoscopic correction of vesicoureteral reflux in children with neurogenic bladder dysfunction. , 1997, The Journal of urology.

[10]  R. Jeffs,et al.  Surgical correction of vesicoureteral reflux in children with neurogenic bladder. , 1976, The Journal of urology.